Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2

Stopped early

Conditions studied: SARS-COV2, Severe Acute Respiratory Syndrome, COVID-19

In brief

The goal of this study is to evaluate if CT (Computerized Tomography) can effectively and accurately predict disease progression in patients with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). You may be eligible if you have been diagnosed with SARS-CoV-2, are an inpatient at Beaumont Hospital-Royal Oak and meet eligibility criteria. After consent and determination of eligibility, enrolled patients will have a CT scanning session. After the CT scan, patients are followed for 30 days by reviewing their medical records and by phone after discharge from hospital.

Key facts

Study ID

NCT04320511

Run by

Corewell Health East

People needed

15

Starts

2020-06-24

Expected to finish

2021-05-14

Last updated by the study team

2022-01-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults >18 years of age
• Written Informed consent
• A confirmed diagnosis of SARS-CoV-2 with mild to moderate disease, on room air or supplemental oxygen not more than 12L
• Concomitant medications for the treatment are allowed

You may not qualify if…

• Patients <18 years
• Pregnant females
• Invasive ventilator support or non-invasive ventilator support including high flow nasal cannula
• COPD or Congestive Heart Failure patients requiring home oxygen
• History of lung cancer and radiation to lung or had prior radiation to the chest

Where it is running

• Beaumont Health — Royal Oak, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.